Newsletter | March 13, 2026

03.13.26 -- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead

SPONSOR

Join Cell & Gene Live Chief Editor Erin Harris on March 19, at 11am Eastern for Materials Matter: Ensuring Quality of CGT Materials. In this live event, experts will explore evolving expectations around material selection, characterization, and sourcing; emerging guidance and standards from USP; how smarter analytics and vendor partnerships can reduce batch failures and CMC setbacks, and more. Register for free thanks to support from our sponsor MilliporeSigma.

FOCUS ON SUPPLY CHAIN

Green Supply Chains Rarely Start With A Pledge; Target Waste Instead

Effective sustainability strategies in pharma supply chains reduce rework and overage. Three leakage points offer the most practical starting point for rooting out waste.

Trends In Cold Chain Storage For Biologics

Packaging is critical, as biotechnology products requiring colder storage become more valuable. Find out how you can improve your temperature-controlled supply chain and meet cold chain storage demands.

FOCUS ON CLINICAL TRIALS

Integrated Early Development Is Rewriting Proof-Of-Concept

Do you want to move faster from First-in-Human to Proof-of-Concept? Learn how integrating real-time manufacturing and clinical data removes the gaps that stall early development programs.

How In-Home Trials Can Shift The Pediatric Rare Disease Research Landscape

Decentralized Clinical Trial (DCT) solutions are not just about bringing the trial to the patient’s home and reducing logistical burdens, but also strengthening the family-researcher connection.

Evolving Landscape Of Payer Coverage For CGTs: Trends And Insights

Examine how proactive payer engagement and robust clinical evidence regarding comparative effectiveness and durability of response can overcome significant reimbursement barriers and enhance patient access.

5 Questions That Put Sponsors Back In Control Of Bioanalysis Projects

Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

CLINICAL TRIALS SOLUTIONS

Starting A New Study? This Article's For You - ClinAI

An End-To-End Clinical Data Science Solution - Revvity Signals Software, Inc.

Connect With Cell & Gene: